We hypothesize that superoxide (O 2 . ) accumulation is not a crucial causative factor in inducing nitroglycerin (NTG) . accumulation may be an effect, rather than an initiating cause, of NTG tolerance.
. production but did not increase NTG-stimulated cGMP production. Using p47 phoxϪ/Ϫ and gp91 phoxϪ/Ϫ mice versus their respective wild-type controls (WT), we showed that aorta from mice null of these critical NADPH oxidase subunits exhibited similar vascular tolerance after NTG dosing (20 mg/kg s.c., t.i.d. for 3 days), as indicated by their ex vivo pEC 50 and cGMP accumulation upon NTG challenge. In vitro aorta O 2 . production was enhanced by NTG incubation in both p47 phox null and WT mice. Pre-exposure of isolated mice aorta to 100 M NTG for 1 h resulted in vascular tolerance toward NTG and increased O 2 . accumulation. Oxypurinol (1 mM) reduced O 2 . but did not attenuate vascular tolerance. These results suggest that O 2 .
does not initiate either in vitro and in vivo NTG tolerance, and that the p47 phox and gp91 phox subunits of NADPH oxidase are not critically required. Increased O 2 . accumulation may be an effect, rather than an initiating cause, of NTG tolerance.
Nitroglycerin (NTG; glyceryl trinitrate) and other organic nitrates have been widely used to treat coronary artery disease in patients with stable and unstable angina, acute myocardial infarction, and congestive heart failure. When administered acutely, NTG relieves ischemic symptoms rapidly without serious side effects. However, its efficacy after repeated dosing is attenuated because of the development of pharmacologic tolerance. This phenomenon was first described by Stewart (1888) in the 19th century, but its underlying mechanism(s) still remained incompletely defined.
Nitrate tolerance is a complex phenomenon accompanied by a myriad of events, including decreased pharmacological response, reduced metabolism, increased oxidative stress, altered gene expression, etc. Consequently, several hypotheses have been proposed to account for these various phenomenon, including those of sulfhydryl depletion, impaired biotransformation of mitochondrial aldehyde dehydrogenase (aldehyde dehydrogenase 2; ALDH2), and oxidative stress, as reviewed recently in Fung (2004) and Mü nzel et al. (2005) .
Mü nzel et al. (1995) found that a prolonged period of NTG exposure in rabbits enhanced superoxide (O 2 . ) production in the blood vessel wall, and they proposed that nitrate tolerance was caused by increased O 2 . formation. Further development of this mechanism, which became known as "the O 2 . -oxidative stress hypothesis," suggested that chronic NTG treatment increases angiotensin II (Ang II) binding to endothelium angiotensin receptors, subsequently stimulating NADPH oxidase (NOX) to produce O 2 . . This oxygen-free radical then reacts with nitric oxide (NO), the putative intermediate of NTG, to form peroxynitrite, an oxidant and a weaker vasodilator than NO. Oxidative stress also brings about uncoupling of endothelial NO synthase (eNOS), resulting in decreased NO availability and further O 2 . formation, and ultimately endothelial dysfunction (Gori and Parker, 2002) . This hypothesis was supported by the attenuating effects of agents that inhibit O 2 . production [e.g., antioxidants such as liposomal superoxide dismutase (Mü nzel et al., 1995) , vitamin C (Bassenge et al., 1998) , vitamin E (Watanabe et al., 1997) , and hydralazine ] and drugs that inhibit the Ang II/NOX pathway (Wada et al., 2002) . A later study suggested that reactive oxygen species produced by NTG may inhibit ALDH2, one of several enzymes responsible for NTG bioactivation (Wenzel et al., 2007 production was observed in tolerant vessels obtained from patients with coronary artery disease, but NTG responsiveness was not altered, suggesting lack of critical involvement of O 2 . in NTG tolerance (Sage et al., 2000) . Using 8-isoprostaglandin F 2␣ and circulating 3-nitrotyrosine and their metabolites as indicators for oxidative stress, Keimer et al. (2003) . in NTG tolerance development, using two separate experimental systems: LLC-PK1 cells and NOX knockout mice. LLC-PK1 cells, derived from a porcine kidney epithelial cell line, have been used as a model for examining the cellular mechanisms of nitrate-induced activation and desensitization of cGMP response in previous studies (Hinz and Schroder, 1998 ). We used this in vitro system here to examine the roles of Ang II and O 2 . in NTG tolerance. Because Ang IImediated NOX stimulation was proposed to be critical for O 2 . production to induce nitrate tolerance (Rajagopalan et al., 1996) , two different strains of knockout mice, null of p47 phox and gp91 phox subunits of NOX, were used to explore their role in mediating O 2 . production and vascular tolerance.
Materials and Methods

Materials
LLC-PK1 cells were obtained from the American Type Culture Collection (Manassas, VA). Ham's F-12 medium, fetal bovine serum, 10 4 U/ml penicillin, 10 mg/ml streptomycin, dihydroethidium (DHE), and nitrocellulose membrane were purchased from Invitrogen (Carlsbad, CA). Adult gp91 phoxϪ/Ϫ mice and wild-type (WT) C57BL/6 controls, 7 to 9 weeks of age, were purchased from The Jackson Laboratory (Bar Harbor, ME), whereas adult p47 phoxϪ/Ϫ and WT C57BL/6 mice were purchased from Taconic Farms (Germantown, NY). NTG (2% powder, adsorbed on lactose) was kindly provided by Copperhead Chemical Company Inc. (Tamaqua, PA). The sources of other materials are indicated as follows: NTG solution (30% propylene glycol, 30% ethanol; Abbott Laboratories, Abbott Park, IL); cGMP enzyme immunoassay kit (Assay Designs, Ann Arbor, MI); and ECL-enhanced chemiluminescence system (Pierce, Rockford, IL). All other chemicals were purchased from SigmaAldrich (St. Louis, MO).
Cell Studies
Cell Culture. LLC-PK1 cells were cultured in Ham's F-12 medium, containing 15% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin. They were maintained in a humidified incubator at 37°C with 5% CO 2 . Cells between passage 6 and 16 were used in all of the experiments.
Detection of cGMP. Cells subcultured in 35-mm culture dishes were grown to confluence and preincubated in basal salt solution (130 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2 , 0.8 mM MgCl 2 , 5.5 mM glucose, and 20 mM HEPES-NaOH, buffered to pH 7.3) for 4 h containing vehicle control (5% dextrose), 1 M NTG, or 1 M Ang II, each with or without 10 mM tiron. At the end of the preincubation, cells were washed twice with phosphate-buffered saline (PBS) and further incubated in basal salt solution in the presence of 0.5 mM isobutylmethylxanthine for 10 min to inhibit cGMP degradation. The cells were then challenged with 3.16 M NTG for 10 min to stimulate cGMP production, which was determined using an enzyme immunoassay kit, and normalized for protein content.
Superoxide Measurement. Flow cytometry was used to quantify the fluorescence signals produced by DHE-superoxide complexes in cells (Mü nzel et al., 2002) . Cells were grown in blank F-12 medium overnight and were suspended in blank medium (5 ϫ 10 6 cells in 2 ml of PBS) on the day of analysis. They were treated with 1 M Ang II or 1 M NTG for 2 h. When tiron and oxypurinol were used, their final concentrations were set at 10 mM and 100 M, respectively. At the end of the incubation, cells were washed with PBS and bathed in fresh F-12 blank medium. A final concentration of 10 nM DHE was added to the medium, and the cells were incubated for 20 min, then washed with ice-cold PBS, and analyzed using a Becton Dickinson FACSCalibur flow cytometer (BD Biosciences, San Jose, CA), using excitation and emission wavelengths at 488 and 585 nm, respectively. BD CellQuest Pro software (BD Biosciences) was used to quantify the fluorescence signal, which was expressed in arbitrary fluorescence units.
Animal Studies
In Vivo NTG Tolerance Induction. Knockout and control mice were housed in a sterile environment to prevent infection. Animals received a mixture of sulfamethoxazole (40 mg/ml) and trimethoprim (8 mg/ml) in their drinking water for 2 days then switched to normal drinking water for 1 day before tolerance induction, as described previously (Wang et al., 2002) . In brief, animals received subcutaneous injections of either NTG (20 mg/kg) or vehicle (lactose solution) three times daily for 3 days. Animals were then sacrificed, and the thoracic aorta was removed for vascular relaxation studies and cGMP measurements (n ϭ 6 -7 each). All of the procedures were performed according to protocols approved by the Institutional Animal Care and Use Committee at the University at Buffalo.
Ex Vivo Vascular Relaxation. The procedures for tissue bath relaxation studies were adopted from Wang et al. (2002) . In brief, after tolerance induction, animals were anesthetized with a mixture of ketamine (90 mg/kg) and xylazine (9 mg/kg). The abdomen was cut open, and the animal was exsanguinated via cardiac puncture. The thoracic aorta was removed and immersed in ice-cold Krebs buffer. The aorta was cleaned of connective tissue and cut into 3-mm wide ring segments. They were then suspended by stainless steel hooks in 10 ml of tissue baths containing Krebs buffer and maintained at 37°C with constant aeration of 5% CO 2 in O 2 . The aorta rings were washed with fresh buffer and equilibrated for 1 h. After equilibration, the aortic rings were precontracted with 4 M phenylephrine. Once the contraction was stabilized, the cumulative NTG dose-response curves were obtained. Ring tensions were measured using isometric transducers and recorded using the PowerLab data acquisition system (ADInstruments, Colorado Springs, CO).
Ex Vivo cGMP Measurement. After NTG tolerance induction, the thoracic aorta was collected as described, and equilibrated in Krebs buffer at 37°C for 30 min in the presence of 0.5 mM isobutylmethylxanthine, and then challenged with 1 M NTG for 30 s. The preparation was immediately frozen in liquid nitrogen and homogenized in 1 ml of hydrochloric acid (0.1 M). The supernatant was collected after centrifugation at 600g for 10 min at 4°C and analyzed for cGMP. The pellet was dissolved in 200 l of sodium hydroxide (1 M) and centrifuged at 600g for 10 min at 4°C to remove the insoluble content, and the resultant supernatant was used for protein analysis. cGMP levels were determined by enzyme immunoassay and normalized for protein content.
In Vitro Aortic Superoxide Measurement. Thoracic aorta from untreated mice was collected as described above. The dissected tissue was tied with thread and incubated in tissue bath in the presence of Krebs buffer for 20 min. Oxypurinol (1 mM) was added and incubated for 15 min followed by the addition of 10 M NTG for an additional 1-h incubation. The tissue was then cut open longitudinally and used for ex vivo vascular relaxation or O 2
. measurements. Aortic O 2 . accumulation was measured by lucigeninenhanced chemiluminescence using a liquid scintillation counter (TRI-CARB 1900CA; Hewlett Packard, Palo Alto, CA) set in out-ofcoincidence mode. The assay medium contained 2 ml of Krebs buffer and 5 M lucigenin, and it was placed in glass scintillation vials and kept in the dark for 30 min. The chemiluminescence from several blank vials was first determined, and the ones with the lowest background counts were selected for use. The assay was initiated by adding the tissue in the dark-adapted scintillation vials, which were kept in the counter for 2 min before counting. After counting, 20 mM O 2 . scavenger tiron was added and incubated in dark for 20 min, and the samples were counted again. Photon emission was measured every 1 min for 5 min. The tissue was dried at 90°C overnight, and the result was expressed as counts per minute per milligram of dry weight.
Statistical Analysis
All data are presented as mean Ϯ S.D. unless otherwise stated. Statistical differences between values were evaluated by either Student's t test or one-way analysis of variance, where appropriate. Statistical significance was determined by Tukey's post hoc test (version 11.x; SPSS Inc., Chicago, IL) after analysis of variance. The EC 50 from the NTG concentration-relaxation response curve was calculated by fitting the data with a Sigmoid-E max model using SigmaPlot (version 8.0; Systat Software, Inc., San Jose, CA). Differences with p Ͻ 0.05 were denoted as statistically significant.
Results
Effects of Ang II or NTG on cGMP Response in LLC-PK1 Cells. Cells exposed to 1 M NTG for 4 h showed significantly reduced cGMP accumulation when stimulated by a challenge concentration of 3.16 M NTG for 10 min (Table 1) , suggesting development of nitrate tolerance (p Ͻ 0.01). Coincubation with 10 mM of vitamin C, but not with 100 M of oxypurinol, partially restored this attenuated response (Table 1) . Coincubation with 10 mM tiron during the 4-h exposure period led to reduced cGMP response in both control and NTG-incubated samples (p Ͻ 0.01). Cells exposed to 1 M Ang II for 4 h, with or without tiron, exhibited cGMP responses similar to those found in control samples ( phoxϪ/Ϫ mice toward NTG was compared with that of WT mice. Figure 1 shows that in both gp91 phoxϩ/ϩ and gp91 phoxϪ/Ϫ animals ( Fig. 1, A and B, respectively), NTG pretreatment for 3 days produced a similar rightward shift in the concentration-relaxation response curves toward NTG over the concentration range of 0.1 nM to 1 mM. The pEC 50 values obtained from both gp91 phoxϩ/ϩ and gp91 phoxϪ/Ϫ mice are shown in Table 2 .
Both p47 phoxϩ/ϩ and p47 phoxϪ/Ϫ mice also exhibited vascular nitrate tolerance after NTG dosing (Fig. 2) . The concentration-relaxation response curves were significantly rightshifted after pretreatment with NTG for 3 days in both WT and knockout mice. The pEC 50 values obtained from both p47 phoxϩ/ϩ and p47 phoxϪ/Ϫ mice are shown in Table 2 . Effect of in Vivo NTG Treatment on cGMP Accumulation in Mouse Aorta. The aortic cGMP levels after in vivo NTG tolerance induction was measured by stimulating the aorta with 1 M NTG ex vivo for 30 s, as described previously (Wang et al., 2002) . NTG-stimulated cGMP production trended higher in both untreated knockout animals than in their corresponding WTs but without statistical difference. 
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In both gp91 phoxϩ/ϩ and gp91 phoxϪ/Ϫ mice, cGMP accumulation was significantly lower (p Ͻ 0.05) in NTG-treated groups compared with vehicle-treated groups (Table 2 ). Similar to gp91 phox gene knockout animals, cGMP accumulation in both p47 phoxϩ/ϩ and p47 phoxϪ/Ϫ mice were significantly lower (p Ͻ 0.05) in NTG-treated animals than vehicle-treated controls ( Table 2) . . concentration was (1.09 Ϯ 0.29) ϫ 10 3 cpm/ mg dry weight, significantly lower than that found in WT mice (p Ͻ 0.05), indicating that the p47 phox knockout mice were indeed functionally unresponsive to Ang II stimulation. . production in mice, the effect of oxypurinol, a xanthine oxidase (XO) inhibitor, on NTG-stimulated O 2 . was assessed. In p47 phoxϩ/ϩ animals, NTG significantly increased O 2 . production, whereas coincubation of 1 mM oxypurinol significantly reduced NTGstimulated O 2 . production ( Fig. 4 ; Table 3 ).
Effect of in Vitro NTG
Discussion
The present study only addressed one of the principal hypotheses of nitrate tolerance, namely, that of oxidative stress caused by O 2 . accumulation, through the Ang II/NOX pathway . In vivo Ang II treatment for 7 days in rats increased the activity and expression of NOX, leading to increased O 2 . production, eNOS uncoupling, impaired NO/cGMP signaling, and endothelial dysfunction (Mollnau et al., 2002) . In healthy human subjects, plasma Ang II increased after continuous transdermal NTG application (Watanabe et al., 1998) , and in rabbits, 3 days of continuous treatment with NTG patches resulted in an increase in Ang II type 1 receptor mRNA expression and a marked increase in constrictions to Ang I and II (Kurz et al., 1999) . These findings led the last group of investigators to conclude "a pathophysiological role for angiotensin II in the development of nitrate tolerance." Despite these findings, the direct relevance of the Ang II/NOX/O 2 . axis in causing vascular tolerance (so-called true tolerance) is not clear. Plasma Ang II levels remained elevated despite avoidance of tolerance via intermittent dosing (Watanabe et al., 1998) , suggesting that the Ang II response might be a result of hemodynamic counter-regulation (socalled pseudotolerance). An obligatory involvement of the endothelium in nitrate tolerance was indicated (Kurz et al., 1999) , but several investigators have found that vascular NTG tolerance can be induced in the absence of the endothelium, and cross-tolerance between NTG and acetylcholine was not observed (Stewart et al., 1987; Mü lsch et al., 1989) . Nitrate tolerance in the rat thoracic aorta was not diminished by endothelium removal (Rapoport et al., 1987) . Using knockout mice, we also showed that eNOS was not critically required for the induction of nitrate tolerance (Wang et al., 2002) .
In this study, we sought to examine the criticality of O 2 . as an initiator of NTG tolerance, using both in vitro and in vivo 
TABLE 3
In vitro vascular relaxation (pEC 50 ) and superoxide production in p47 phoxϩ/ϩ mice aorta after in vitro NTG (10 M for 1 h) and oxypurinol (1 mM for 15 min) treatments. . Ex vivo concentration versus relaxation curves of isolated mouse aorta toward NTG in p47 phoxϩ/ϩ mice. F, aorta treated with vehicle; E, aorta treated with NTG; , aorta pretreated with oxypurinol followed by vehicle; ‚, aorta pretreated with oxypurinol followed by NTG. The dashed lines showed a rightward shift of the NTG-relaxation curves versus their corresponding control, consistent with vascular tolerance development. Data are expressed as mean Ϯ S.D., n ϭ 6 -7 animals.
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at ASPET Journals on July 8, 2017 jpet.aspetjournals.org approaches. We first examined the feasibility of using cultured human vascular smooth muscle cells (HuVSMC) (CRL-1999; American Type Culture Collection) instead of LLC-PK1 cells. Consistent with literature findings (Bennett et al., 1989) (Benov et al., 1998) . Whereas several studies showed that angiotensin-converting enzymes inhibitors or Ang II-receptor antagonists can reverse or prevent nitrate tolerance (Cotter et al., 1998) , this beneficial effect was not always observed (Dakak et al., 1990; Longobardi et al., 2004) . In larger clinical trials, such as GISSI-3 (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico) and ISIS-4 (Fourth International Study of Infarct Survival), there was no significant evidence that the effect of nitrate therapy was different in the presence or absence of angiotensin-converting enzymes inhibitors. Consistent with these latter findings, the present results indicate that Ang II-stimulated O 2
. accumulation was not critically involved in producing cellular nitrate tolerance, at least in LLC-PK1 cells. We used NOX knockout mice to examine the critical participation of NOX in O 2
. production and tolerance induced by NTG. The strains used here were p47 phox and gp91 phox knockout mice. Both gp91 phox and p47 phox are crucial for NOX to be functionally active. Our vascular relaxation results of the gp91 phox and p47 phox knockout mice showed similar right-ward shifts in NTG dose-response curves, with 3 to 6-fold changes in EC 50 values after in vivo NTG treatment ( Figs. 1 and 2 ; Table 2 ). NTG-stimulated cGMP levels in the aorta was measured as a second indicator for nitrate tolerance (Table 2) . In both strains, the cGMP levels were attenuated to a comparable extent after in vivo NTG treatment (approximately 55% decrease), consistent with the results obtained in the vascular relaxation experiments.
Ang II infusion caused a 2 to 3-fold increase in vascular O 2 . production in p47 phoxϩ/ϩ but not in p47 phoxϪ/Ϫ mice (Landmesser et al., 2002) , indicating a "pivotal" role for p47 phox in vascular oxidative and blood pressure response to Ang II in vivo. p47 phox has only one homolog (NOX organizer 1), which is mainly observed in the colon but not in vascular tissues (Quinn et al., 2006 . were produced in both WT and knockout animals when treated with NTG compared with their corresponding vehicle control (Fig. 3) . Whereas no difference in eNOS and XO protein expression in p47 phoxϪ/Ϫ mice versus WT mice was observed in one study (Li et al., 2004) , another study found that endothelial cells lacking the p47 phox subunit had minimal XO protein and activity (McNally et al., 2003) . Our finding that NTG induced less O 2
. formation in p47 phox knockout versus WT mice (Fig. 3) is therefore more consistent with the latter observation.
The ability of oxypurinol to reduce NTG-mediated O 2 . production was seen in both LLC-PK1 cells (Table 1) and WT mice (Table 3) , but it did not alter the extent of in vitro aorta tolerance (Fig. 4) . Oxypurinol was chosen over its prodrug allopurinol, which produces O 2 . in the biotransformation process (Galbusera et al., 2006) . Our result differed from that of Mü nzel et al. (1995) , who found no effect of 1 mM oxypurinol on vascular O 2 . production in NTG-tolerant vessels isolated from rabbits that have been treated with NTG patch (0.4 mg/h) for 3 days. These dissimilar observations may have arisen from species and methodological differences. The lack of crucial involvement of Ang II and NOX-mediated O 2 . in this study supports our view that oxidative stress may be a byproduct of nitrate tolerance rather than its cause. We hypothesize that protein S-oxidation, rather than the Ang II/NOX/O 2 . pathway, may be the initiating step for NTG metabolism and tolerance (Fung, 2004) . We suggest further that the increased O 2 . observed in nitrate tolerance can result from protein S-oxidation, as indicated by our results in experiments involving XO. This enzyme, together with xanthine dehydrogenase (XDH), belongs to the xanthine oxidoreductase (XOR) system. XDH is the predominant form of XOR and upon activation, it is converted to XO via reversible S-oxidation or irreversible partial proteolysis (Borges et al., 2002) . Both XDH and XO are capable of producing O 2 . .
Being flavoproteins, XOR have been shown to reduce nitrates into inorganic nitrites under anaerobic conditions (Doel et al., 2001) . The specific biochemical interactions between NTG and XDH/XO are currently under examination in our laboratory.
In conclusion, we showed that in two separate experimental systems, O 2 . is not critically responsible for developing nitrate tolerance. Figure 5A illustrates . generation nor the involvement of the AngII/NOX pathway are critical for the initiation of this phenomenon, at least in the two experimental systems that we studied. 
